Showing results (21-30 of 445,205) with videos related to
Sort By:
Pageof 44,521
FEBS Letters|October 6, 2000
Epoxysuccinyl peptide-derived affinity labels for cathepsin BN Schaschke, I Assfalg-Machleidt, T Lassleben, et al.Bioorganic & Medicinal Chemistry Letters|April 13, 2000
Beta-cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cellsN Schaschke, I Assfalg-Machleidt, W Machleidt, et al.The Biochemical Journal|May 7, 1999
Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genisteinC Randak, E A Auerswald, I Assfalg-Machleidt, et al.Journal of Protein Chemistry|June 10, 1998
Isolation and characterization of two forms of an acidic bromelain stem proteinaseT Harrach, K Eckert, H R Maurer, et al.FEBS Letters|June 30, 1997
A recombinant polypeptide model of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator functions as an active ATPase, GTPase and adenylate kinaseC Randak, P Neth, E A Auerswald, et al.FEBS Letters|August 12, 1996
Cyclodextrins as templates for the presentation of protease inhibitorsN Schaschke, H J Musiol, I Assfalg-Machleidt, et al.Der Nervenarzt|August 10, 2004
[Coenaesthesia after infection with Varicella zoster virus. The psychodynamic meaning of suffering a children's disease at adult age]B R Brüggemann, W MachleidtBiological Chemistry|July 11, 2002
Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratinNorbert Schaschke, Dominga Deluca, Irmgard Assfalg-Machleidt, et al.Biological Chemistry Hoppe-Seyler|October 1, 1988
Inhibitorily active recombinant human stefin B. Gene synthesis, expression and isolation of an inhibitory active MS-2 pol-stefin B fusion protein and preparation of Des[Met1,2(2)]stefin BU Thiele, E A Auerswald, W Gebhard, et al.Fortschritte Der Neurologie-Psychiatrie|January 5, 2008
[Socialpsychiatric and ethical reflections about prevention of schizophrenic disorders]W Machleidt, B R BrüggemannPageof 44,521